Quince Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QNCX and other ETFs, options, and stocks.About QNCX
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes EryDex, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells.
CEODirk Thye
CEODirk Thye
Employees36
Employees36
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2012
Founded2012
Employees36
Employees36
QNCX Key Statistics
Market cap44.15M
Market cap44.15M
Price-Earnings ratio-0.68
Price-Earnings ratio-0.68
Dividend yield—
Dividend yield—
Average volume476.53K
Average volume476.53K
High today$0.9764
High today$0.9764
Low today$0.902
Low today$0.902
Open price$0.902
Open price$0.902
Volume180.91K
Volume180.91K
52 Week high$2.45
52 Week high$2.45
52 Week low$0.5116
52 Week low$0.5116
People also own
Based on the portfolios of people who own QNCX. This list is generated using Robinhood data, and it’s not a recommendation.